HIV Vaccine Fails Clinical Trial in South Africa

HIV Vaccine Fails Clinical Trial in South Africa

Story Highlights Another attempt to create an effective vaccine against the Human Immunodeficiency Virus (HIV) has been stopped early because it was not found to prevent HIV infection. It is estimated that 1,000 people are newly infected every day in South Africa. HIV virus appears to evade and destroy cells of the immune system and […]

Moderna to Use New mRNA Technology to Develop Coronavirus Vaccine

Moderna to Use New mRNA Technology to Develop Coronavirus Vaccine

Story Highlights In light of the coronavirus outbreak, three research teams have been awarded grants by the Coalition for Epidemic Preparedness Innovations to develop a vaccine for the novel coronavirus. In a public-private partnership with NIH, Moderna, Inc. is using an experimental mRNA technology to develop a vaccine. Johnson & Johnson and other drug companies […]

Injecting TB Vaccines Into the Veins vs Reducing Poverty

Injecting TB Vaccines Into the Veins vs Reducing Poverty

The journal Nature recently reported that tuberculosis (TB) vaccine developers discovered TB vaccine is much more effective if it is injected directly into the veins of monkeys rather than into the skin. Researchers at the University of Pittsburgh School of Medicine and the National Institute of Allergy and Infectious Diseases (NIAID) found that administering BCG—the […]

Quest for Universal Flu Vaccine Boosted by $200M NIH Grant to University of Maryland

Quest for Universal Flu Vaccine Boosted by $200M NIH Grant to University of Maryland

Story Highlights National Institutes of Health (NIH) has awarded the University of Maryland a contract for more than $200 million to develop a universal influenza vaccine. Currently, the influenza vaccine used around the world is developed every year by drug companies based on the “best guesses” made by public health officials at the World Health […]

NIH and Johnson & Johnson to Begin HIV Vaccine Trials on Humans

NIH and Johnson & Johnson to Begin HIV Vaccine Trials on Humans

Story Highlights NIH, in collaboration with Johnson & Johnson, will begin HIV vaccine efficacy trials on humans in August 2019 in the U.S. Another HIV vaccine candidate, using a live attenuated herpes cytomegalovirus (CMV), is also nearing clinical trials in humans. There are serious safety concerns regarding live attenuated vaccines and numerous cases reported in […]